Skip to main content

Table 3 Characteristics of individual response groups with regard to skeletal muscle strength and pulmonary function

From: Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study

 

Non-responders

Moderate Responders

Good responders

P-value

Response groups for MRC sumscore – No. of patients (%)

6 (9)

32 (46)

31 (45)

 

Female – No. of patients (%)

1 (17)

11 (34)

21 (68)

0.002

Age at start of ERT in years – median (range)

51.6 (38.0 – 66.2)

50.0 (26.2 – 67.0)

52.7 (29.2 – 76.3)

0.47

Disease duration at start of ERT in years – median (range)

12.1 (3.6 – 22.7)

11.1 (0.9 – 31.2)

9.0 (0.2 – 29.1)

0.55

MRC sumscore at start of ERT in percentage – median (range)

80.8 (60.8 – 86.9)

80.0 (48.3 – 91.5)

74.6 (53.3 – 92.3)

0.12

Wheelchair use at start of ERT – No. of patients (%)

2 (33)

9 (28)

16 (52)

0.11

FVC in upright position at start of ERT in percentage – median (range)

61.5 (34.4 – 79.3)

69.9 (11.3 – 105.0)

69.3 (16.4 – 106.9)

0.48

Ventilation use at start of ERT – No. of patients (%)

1 (17)

12 (38)

12 (39)

0.49

Response groups for FVC in upright position – No. of patients (%)

9 (15)

26 (42)

27 (44)

 

Female – No. of patients (%)

5 (56%)

14 (54%)

13 (48%)

0.64

Age at start of ERT in years – median (range)

52.6 (31.9 – 69.2)

51.2 (35.7 – 71.7)

43.3 (26.2 – 76.3)

0.16

Disease duration at start of ERT in years – median (range)

8.3 (0.6 – 31.2)

14.1 (0.9 – 27.0)

4.7 (0.2 – 29.1)

0.06

MRC sumscore at start of ERT in percentage – median (range)

74.6 (63.1 – 91.5)

77.7 (48.3 – 90.0)

80.8 (67.5 – 92.3)

0.26

Wheelchair use at start of ERT – No. of patients (%)

4 (44%)

10 (38%)

6 (22%)

0.15

FVC in upright position at start of ERT in percentage – median (range)

66.6 (51.4 – 100.5)

68.3 (11.3 – 106.9)

69.9 (16.4 – 105.0)

0.95

Ventilation use at start of ERT – No. of patients (%)

2 (22)

8 (31)

8 (30)

0.76

Response groups for FVC in supine position – No. of patients (%)

21 (39)

17 (31)

16 (30)

 

Female – No. of patients (%)

10 (48)

10 (59)

10 (63)

0.36

Age at start of ERT in years – median (range)

51.7 (31.9 – 67.0)

47.9 (26.2 – 62.9)

40.4 (29.2 – 74.0)

0.007

Disease duration at start of ERT in years – median (range)

10.7 (0.6 – 31.2)

4.7 (0.5-21.0)

5.0 (0.9 – 29.1)

0.12

MRC sumscore at start of ERT in percentage – median (range)

76.9 (60.8 – 91.5)

80.8 (69.2 – 90.8)

81.9 (69.2 – 92.3)

0.02

Wheelchair use at start of ERT – No. of patients (%)

8 (38)

2 (12)

2 (13)

0.05

FVC in upright position at start of ERT in percentage – median (range)

66.6 (45.4 – 106.9)

65.7 (41.5 – 105.8)

81.0 (62.6 – 105.0)

0.02

Ventilation use at start of ERT – No. of patients (%)

4 (19)

6 (35)

0 (0)

0.01

  1. ERT = Enzyme Replacement Therapy; MRC sumscore = Medical Research Council sumscore; FVC = Forced Vital Capacity; No. = Number of patients.